Wednesday, 21 Feb 2018

PsA/SpA

Datesort ascending Type Title Save
07 Nov 2017 Social RT @doctorakerkar: PsA- Dissociation between patient & physician perspectives about the disease activity? #2553 #ACR17 @RheumNow https://t…
07 Nov 2017 Social RT @psufka: Don't discount spondyloarthropathy in pts >45yo, esp if pt has psoriasis or inflammatory back pain. #ACR17 @RheumNow #2037 http…
07 Nov 2017 Social RT @philipcrobinson: For those that treat refractory anterior uveitis there is a great review on use of DMARDs at poster/abstract 2098 #ACR…
07 Nov 2017 News IL-17 Inhibition with Secukinumab in PsA: X-Ray Outcomes
07 Nov 2017 Social RT @japaoli19: Low dmard use on AS pts on chronic opioids #1548 #ACR17 @RheumNow https://t.co/7vks8vgV9y
07 Nov 2017 Social RT @DrPetryna: FUTURE5: Cosentyx clinically&radiofraph superior toPBO. mTSS non-progression 88%Cosentyx vs73% PBO #L17 #acr17 @RheumNow htt…
07 Nov 2017 Social RT @japaoli19: Dheodar et al-Large study on impact of TNFi on xtra art. comorbidities in AS #1527 #ACR17 @RheumNow https://t.co/xwyUtXkliq
07 Nov 2017 Social RT @uptoTate: Dr. Mease presenting late breaking abstract 17L on secukinumab and delaying radiographic progression in PsA. #ACR17 @rheumnow…
07 Nov 2017 ACR Video Dr. Julio Gonzalez: Psoriatic Arthritis and Axial Spondyloarthropathy Studies
07 Nov 2017 Social RT @cwrightmd: @psufka There were tweets about Landewe’s abstract in SpA... https://t.co/I847KS3cVk https://t.co/81ZfAfiBTl https://t.co/b4…
07 Nov 2017 Social RT @Janetbirdope: #GAMECHANGER. Ankylosing spondylitis genetics are biased AS parent is more likely to have AS in sons #acr17 @rheumnow #1
07 Nov 2017 Social RT @uptoTate: Diagnostic, elemental ultrasonographic abnormalities in PsA. Possible diagnostic criteria? #ACR17 @RheumNow #1874 https://t.c…
06 Nov 2017 Social RT @ARD_BMJ: SIJ MRI oedema may be found in many healthy runners @ACRheum #ACR17 https://t.co/l8RtAZvqtJ
06 Nov 2017 Social RT @DrPetryna: #1881 #acr17 Uveitis&scleritis common in AI disease. Lack of consensus on workup guidelines calls for Ophtho/rheum collabora…
06 Nov 2017 Social RT @japaoli19: Significant reduction in immunosuppression load on uveitis pts with long term ADA use. #ACR17 @RheumNow #1115 https://t.co/…
06 Nov 2017 Social RT @uptoTate: What is your 1st line, post DMARD, treatment of advanced active PsA? #ACR17 @RheumNow
06 Nov 2017 Social RT @philipcrobinson: Persistence of MTX at week 24 in PSA is 83%. Not as bad as some people make out #ACR17 @RheumNow Abs 1252 https://t.co…
06 Nov 2017 Social RT @doctorakerkar: Developments to watch for- IL-23 important factor in enthesitis #ACR17 https://t.co/jFrpneTUBL
06 Nov 2017 Social RT @ACRheum: Collaborative ACR/NPF effort yields new clinical guideline for treatment of adult patients w/ active PsA. https://t.co/uw1VFWD…
06 Nov 2017 Social RT @pkiely500: #ACR17 Landewe. Stopping adalimumab in nrAxSpA patients in sustained remission leads to flare after 8-12 weeks in 53% https:…